CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 277 filers reported holding CLOVIS ONCOLOGY INC in Q2 2017. The put-call ratio across all filers is 0.51 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $160,000 | -17.5% | 27,575 | +0.0% | 0.01% | -26.7% |
| Q1 2021 | $194,000 | -26.0% | 27,574 | -29.1% | 0.02% | -37.5% |
| Q2 2020 | $262,000 | -65.7% | 38,874 | -67.7% | 0.02% | -80.8% |
| Q1 2020 | $764,000 | -39.0% | 120,174 | 0.0% | 0.12% | -37.8% |
| Q4 2019 | $1,253,000 | +99.8% | 120,174 | +463.0% | 0.20% | +235.0% |
| Q3 2018 | $627,000 | -51.2% | 21,344 | -24.5% | 0.06% | -67.4% |
| Q2 2018 | $1,285,000 | -10.1% | 28,260 | +4.3% | 0.18% | -8.0% |
| Q1 2018 | $1,430,000 | -23.4% | 27,085 | -1.3% | 0.20% | -33.3% |
| Q4 2017 | $1,867,000 | -0.4% | 27,450 | +20.6% | 0.30% | +11.1% |
| Q3 2017 | $1,875,000 | -8.7% | 22,760 | +3.8% | 0.27% | -14.0% |
| Q2 2017 | $2,053,000 | +45.3% | 21,925 | -1.2% | 0.31% | +45.4% |
| Q1 2017 | $1,413,000 | +37.9% | 22,200 | -3.8% | 0.22% | +28.6% |
| Q4 2016 | $1,025,000 | -29.4% | 23,075 | -42.7% | 0.17% | -23.6% |
| Q3 2016 | $1,452,000 | +159.3% | 40,275 | -1.3% | 0.22% | +144.4% |
| Q2 2016 | $560,000 | -47.3% | 40,790 | -26.3% | 0.09% | +1.1% |
| Q1 2016 | $1,062,000 | -48.7% | 55,335 | -6.5% | 0.09% | -73.3% |
| Q4 2015 | $2,072,000 | -74.1% | 59,195 | -31.9% | 0.33% | -73.6% |
| Q3 2015 | $7,991,000 | +24.0% | 86,895 | +18.5% | 1.26% | +27.2% |
| Q2 2015 | $6,446,000 | – | 73,345 | – | 0.99% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $60,485,054,000 | 53.20% |
| Palo Alto Investors LP | 2,121,857 | $157,505,000 | 7.79% |
| NEA Management Company, LLC | 2,279,781 | $169,228,000 | 7.65% |
| EcoR1 Capital, LLC | 243,048 | $18,041,000 | 6.01% |
| Redmile Group, LLC | 900,879 | $66,872,000 | 6.00% |
| Opaleye Management Inc. | 140,000 | $10,392,000 | 4.82% |
| PFM Health Sciences, LP | 2,266,756 | $168,261,000 | 4.64% |
| Partner Investment Management, L.P. | 40,798 | $3,028,000 | 4.56% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 826,919 | $61,383,000 | 3.74% |
| Opus Point Partners Management, LLC | 55,988 | $4,156,000 | 3.48% |